#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	2776	16S	1529	1529	99.87	16S.l15.c4.ctg.1	2171	232.2	0	.	n	.	0	G1207A	SNP	1207	1207	G	1391	1391	A	355	A	213	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	2776	16S	1529	1529	99.87	16S.l15.c4.ctg.1	2171	232.2	0	.	n	.	0	C1450T	SNP	1450	1450	C	1634	1634	T	316	T	187	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	2776	16S	1529	1529	99.87	16S.l15.c4.ctg.1	2171	232.2	1	SNP	n	C1184T	0	.	.	1184	1184	C	1368	1368	C	308	C	189	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	5314	23S	2890	2890	99.93	23S.l15.c17.ctg.1	3421	275.4	0	.	n	.	0	G1337A	SNP	1337	1337	G	1582	1582	A	270	A	163	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	5314	23S	2890	2890	99.93	23S.l15.c17.ctg.1	3421	275.4	0	.	n	.	0	T1971C	SNP	1971	1971	T	2216	2216	C	295	C	169	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	5314	23S	2890	2890	99.93	23S.l15.c17.ctg.1	3421	275.4	1	SNP	n	A2045G	0	.	.	2045	2045	A	2290	2290	A	281	A	166	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	5314	23S	2890	2890	99.93	23S.l15.c17.ctg.1	3421	275.4	1	SNP	n	C2597T	0	.	.	2597	2597	C	2842	2842	C	288	C,A	188,1	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_F_01537c	folP.WHO_F_01537c	1	1	539	168	folP	852	852	99.77	folP.l15.c4.ctg.1	1676	17.4	0	.	p	.	0	D71H	NONSYN	211	213	GAT	843	845	CAT	25;25;25	C;A;T	16;15;16	.	.
folP.WHO_F_01537c	folP.WHO_F_01537c	1	1	539	168	folP	852	852	99.77	folP.l15.c4.ctg.1	1676	17.4	0	.	p	.	0	A204V	NONSYN	610	612	GCA	1242	1244	GTA	28;28;28	G;T;A	18;18;18	.	.
folP.WHO_F_01537c	folP.WHO_F_01537c	1	1	539	168	folP	852	852	99.77	folP.l15.c4.ctg.1	1676	17.4	1	SNP	p	R228S	0	.	.	682	684	CGC	1314	1316	CGC	28;28;27	C;G;C	18;19;17	folP.WHO_F_01537c:1:1:R228S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	513	552	gyrA	2751	2292	99.78	gyrA.l15.c4.ctg.1	2599	32.6	0	.	p	.	0	M250I	NONSYN	748	750	ATG	1055	1057	ATA	24;23;23	A;T;A	16;13;14	.	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	513	552	gyrA	2751	2292	99.78	gyrA.l15.c4.ctg.1	2599	32.6	1	SNP	p	S91F	0	.	.	271	273	TCC	578	580	TCC	54;54;54	T;C;C	35;35;35	gyrA.WHO_F_00668c:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	513	552	gyrA	2751	2292	99.78	gyrA.l15.c4.ctg.1	2599	32.6	1	SNP	p	D95N	0	.	.	283	285	GAC	590	592	GAC	59;59;59	G;A;C	39;36;39	gyrA.WHO_F_00668c:1:1:D95N:gyrA.95N:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	513	552	gyrA	2751	2292	99.78	gyrA.l15.c4.ctg.1	2599	32.6	1	SNP	p	D95G	0	.	.	283	285	GAC	590	592	GAC	59;59;59	G;A;C	39;36;39	gyrA.WHO_F_00668c:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	513	552	gyrA	2751	433	100.0	gyrA.l15.c4.ctg.2	704	23.6	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
mtrR.WHO_W_01449	mtrR.WHO_W_01449	1	1	531	184	mtrR	633	633	99.68	mtrR.l15.c4.ctg.1	1183	28.6	0	.	p	.	0	W136trunc	TRUNC	406	406	T	768	768	T	21	T	11	.	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	19	166	mtrR_promoter	250	250	100.0	mtrR_promoter.l15.c4.ctg.1	728	37.0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
parC.WHO_G_00206c	parC.WHO_G_00206c	1	1	539	394	parC	2304	2304	99.74	parC.l15.c4.ctg.1	2586	27.7	0	.	p	.	0	V435A	NONSYN	1303	1305	GTG	1451	1453	GCA	42;44;44	G;C;A	28;28;27	.	.
parC.WHO_G_00206c	parC.WHO_G_00206c	1	1	539	394	parC	2304	2304	99.74	parC.l15.c4.ctg.1	2586	27.7	1	SNP	p	D86N	0	.	.	256	258	GAC	404	406	GAC	24;24;24	G;A;C	15;14;15	parC.WHO_G_00206c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_G_00206c	parC.WHO_G_00206c	1	1	539	394	parC	2304	2304	99.74	parC.l15.c4.ctg.1	2586	27.7	1	SNP	p	S87R	0	.	.	259	261	AGT	407	409	AGT	24;25;25	A;G;T	15;16;16	parC.WHO_G_00206c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_G_00206c	parC.WHO_G_00206c	1	1	539	394	parC	2304	2304	99.74	parC.l15.c4.ctg.1	2586	27.7	1	SNP	p	S87W	0	.	.	259	261	AGT	407	409	AGT	24;25;25	A;G;T	15;16;16	parC.WHO_G_00206c:1:1:S87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_G_00206c	parC.WHO_G_00206c	1	1	539	394	parC	2304	2304	99.74	parC.l15.c4.ctg.1	2586	27.7	1	SNP	p	S87I	0	.	.	259	261	AGT	407	409	AGT	24;25;25	A;G;T	15;16;16	parC.WHO_G_00206c:1:1:S87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_G_00206c	parC.WHO_G_00206c	1	1	539	394	parC	2304	2304	99.74	parC.l15.c4.ctg.1	2586	27.7	1	SNP	p	S88P	0	.	.	262	264	TCC	410	412	TCC	25;25;25	T;C;C	15;16;16	parC.WHO_G_00206c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	382	parE	1986	1986	99.95	parE.l15.c4.ctg.1	2755	25.9	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1556	1558	GGC	22;22;22	G;G;C	14;14;14	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.1.001	penA.1.001	1	1	527	498	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2073	40.3	1	SNP	p	A311V	0	.	.	931	933	GCA	1086	1088	GCA	57;57;55	G;C;A	37;37;37	penA.1.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.1.001	penA.1.001	1	1	527	498	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2073	40.3	1	SNP	p	I312M	0	.	.	934	936	ATC	1089	1091	ATC	59;59;59	A;T;C	37;38;38	penA.1.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.1.001	penA.1.001	1	1	527	498	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2073	40.3	1	SNP	p	V316P	0	.	.	946	948	GTG	1101	1103	GTG	59;59;59	G;T;G	38;35;38	penA.1.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.1.001	penA.1.001	1	1	527	498	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2073	40.3	1	SNP	p	V316T	0	.	.	946	948	GTG	1101	1103	GTG	59;59;59	G;T;G	38;35;38	penA.1.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.1.001	penA.1.001	1	1	527	498	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2073	40.3	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1605	1607	ACC	21;21;21	A;C;C	11;13;13	penA.1.001:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.1.001	penA.1.001	1	1	527	498	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2073	40.3	1	SNP	p	A502V	0	.	.	1504	1506	GCG	1659	1661	GCG	17;17;17	G;C;G	11;11;11	penA.1.001:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.1.001	penA.1.001	1	1	527	498	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2073	40.3	1	SNP	p	A502P	0	.	.	1504	1506	GCG	1659	1661	GCG	17;17;17	G;C;G	11;11;11	penA.1.001:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.1.001	penA.1.001	1	1	527	498	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2073	40.3	1	SNP	p	G543S	0	.	.	1627	1629	GGC	1782	1784	GGC	10;10;10	G;G;C	8;8;6	penA.1.001:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.1.001	penA.1.001	1	1	527	498	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2073	40.3	1	SNP	p	G546S	0	.	.	1636	1638	GGC	1791	1793	GGC	9;9;9	G;G;C	7;7;7	penA.1.001:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.1.001	penA.1.001	1	1	527	498	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2073	40.3	1	SNP	p	P552S	0	.	.	1654	1656	CCG	1809	1811	CCG	12;12;12	C;C;G	7;6;7	penA.1.001:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.1.001	penA.1.001	1	1	527	498	penA	1749	468	99.57	penA.l15.c4.ctg.2	468	3.0	0	.	p	.	0	F161fs	FSHIFT	481	481	T	163	163	T	ND	ND	ND	.	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	1126	ponA	2397	2397	99.96	ponA.l15.c4.ctg.1	3157	60.5	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
porA.NCCP11945	porA.NCCP11945	1	0	519	268	porA	1146	163	100.0	porA.l15.c4.ctg.1	450	1.5	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
porA.NCCP11945	porA.NCCP11945	1	0	519	268	porA	1146	1146	99.83	porA.l15.c4.ctg.2	1436	29.4	0	.	p	.	0	M83fs	FSHIFT	247	247	A	311	311	C	22	C	14	.	.
porA.NCCP11945	porA.NCCP11945	1	0	519	268	porA	1146	163	100.0	porA.l15.c4.ctg.3	454	7.7	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	260	porB1b	1047	1047	98.38	porB1b.l6.c4.ctg.1	1753	27.1	0	.	p	.	0	T18M	NONSYN	52	54	ACG	480	482	ATG	28;28;29	A;T,A;G	21;15,2;18	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	260	porB1b	1047	1047	98.38	porB1b.l6.c4.ctg.1	1753	27.1	0	.	p	.	0	K143Q	NONSYN	427	429	AAA	855	857	CAA	36;36;36	C;A;A	24;24;22	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	260	porB1b	1047	1047	98.38	porB1b.l6.c4.ctg.1	1753	27.1	0	.	p	.	0	E212D	NONSYN	634	636	GAA	1062	1064	GAT	28;29;29	G;A;T	17;17;16	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	260	porB1b	1047	1047	98.38	porB1b.l6.c4.ctg.1	1753	27.1	0	.	p	.	0	H213D	NONSYN	637	639	CAT	1065	1067	GAT	29;29;29	G;A;T	17;18;18	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	260	porB1b	1047	1047	98.38	porB1b.l6.c4.ctg.1	1753	27.1	0	.	p	.	0	Q214Y	NONSYN	640	642	CAA	1068	1070	TAT	29;29;28	T;A;T	17;18;17	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	260	porB1b	1047	1047	98.38	porB1b.l6.c4.ctg.1	1753	27.1	0	.	p	.	0	V215D	NONSYN	643	645	GTT	1071	1073	GAT	28;26;26	G;A;T	16;17;15	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	260	porB1b	1047	1047	98.38	porB1b.l6.c4.ctg.1	1753	27.1	0	.	p	.	0	I218T	NONSYN	652	654	ATC	1080	1082	ACC	27;29;29	A;C;C	16;19;18	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	260	porB1b	1047	1047	98.38	porB1b.l6.c4.ctg.1	1753	27.1	0	.	p	.	0	R257M	NONSYN	769	771	AGG	1197	1199	ATG	31;29;29	A;T;G	19;17;16	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	260	porB1b	1047	1047	98.38	porB1b.l6.c4.ctg.1	1753	27.1	0	.	p	.	0	R258S	NONSYN	772	774	AGG	1200	1202	AGC	29;30;30	A;G;C	15;16;16	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	260	porB1b	1047	1047	98.38	porB1b.l6.c4.ctg.1	1753	27.1	0	.	p	.	0	A259G	NONSYN	775	777	GCT	1203	1205	GGT	30;30;30	G;G;T	17;19;19	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	260	porB1b	1047	1047	98.38	porB1b.l6.c4.ctg.1	1753	27.1	0	.	p	.	0	D297N	NONSYN	889	891	GAC	1317	1319	AAC	36;36;36	A;A;C	24;24;24	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	260	porB1b	1047	1047	98.38	porB1b.l6.c4.ctg.1	1753	27.1	1	SNP	p	G120K	0	.	.	358	360	GGC	786	788	GGC	31;31;31	G;G;C	21;20;21	porB1b.WHO_P_02204c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_F_02153c	rpoB.WHO_F_02153c	1	1	539	1440	rpoB	4179	4179	99.98	rpoB.l15.c17.ctg.1	4922	52.5	0	.	p	.	0	A998V	NONSYN	2992	2994	GCA	3275	3277	GTA	35;35;35	G;T;A	23;22;22	.	.
rpoB.WHO_F_02153c	rpoB.WHO_F_02153c	1	1	539	1440	rpoB	4179	4179	99.98	rpoB.l15.c17.ctg.1	4922	52.5	1	SNP	p	H553N	0	.	.	1657	1659	CAT	1940	1942	CAT	47;45;45	C;A;T	32;31;31	rpoB.WHO_F_02153c:1:1:H553N:rpoB.553N:H552N. High-level resistance to Rifampicin	.
rpsJ.WHO_F_02142c	rpsJ.WHO_F_02142c	1	1	27	92	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1122	15.5	1	SNP	p	V57M	0	.	.	169	171	GTG	683	685	GTG	32;32;33	G;T;G	20;20;21	rpsJ.WHO_F_02142c:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
